Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
Status:
Completed
Trial end date:
2019-05-30
Target enrollment:
Participant gender:
Summary
This study investigates efficacy, safety and pharmacokinetics of adalimumab in Japanese
subjects with moderate to severe hidradenitis suppurativa (HS).